IO Biotech Mean Deviation
| IOBT Stock | | | USD 0.004 -0.0003 -6.98% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is IO Biotech's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
A Mean Deviation of 12.19 for IO Biotech signals elevated price variability. This places IO Biotech toward the higher end of the volatility range for Biotechnology.
Mean Deviation | = | SUM(RET DEV)N |
| = | 12.19 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of IO Biotech |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
The peer group averages 5.12 for Mean Deviation, with IO Biotech at 12.19 falling above that level. Readings span 3.4 (Adicet Bio) to 10.84 (Cue Biopharma). IO Biotech has exhibited greater price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for IO Biotech and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Mean Deviation (
12.19 ) to Maximum Drawdown (
134.96 ) for IO Biotech yields a
11.07 multiple. This indicates Maximum Drawdown substantially exceeds Mean Deviation for IO Biotech.
Methodology, Assumptions & Data Sources
The current Mean Deviation for IO Biotech is 12.19. IO Biotech's Mean Deviation is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. IO Biotech operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators